Clinical Trials Logo

Aspirin Hypersensitivity clinical trials

View clinical trials related to Aspirin Hypersensitivity.

Filter by:
  • None
  • Page 1

NCT ID: NCT02848339 Completed - Clinical trials for Aspirin Hypersensitivity

Aspirin Desensitization Registry in Patients With Aspirin Hypersensitivity

ADAPTED
Start date: May 2010
Phase: N/A
Study type: Observational [Patient Registry]

Data about aspirin desensitization for patients with coronary artery disease undergoing percutaneous coronary intervention are sparse. This is a prospective, multicenter, observational study including 7 italian centers, to assess safety and feasibility of a standard desensitization protocol in patients with aspirin sensitivity undergoing coronary angiography. Patients with history of aspirin sensitivity undergoing coronary angiography are prospectively enrolled.All patients underwent the desensitization procedure with six sequential doses of aspirin (1, 5, 10, 20, 40, and 100 mg) administered orally at predefined intervals, with the procedure lasting 5.5 hours.All patients are followed for desensitization procedure success, description of reactions due to the desensitization procedure, and in hospital major adverse cardiac events (MACE). All patients are also followed-up for 12 months in order to assess their long-term risk of MACE, compliance with ASA therapy, and late occurrence of side reactions due to ASA sensitivity.

NCT ID: NCT00815126 Completed - Clinical trials for Aspirin Hypersensitivity

Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity

Start date: November 2008
Phase: N/A
Study type: Interventional

This study aims to compare the efficacy of nasal provocation test with Lysine-Acetylsalicylate in patients with history of NSAIDs hypersensitivity between mucocutaneous symptoms and respiratory symptoms and laboratory outcomes.